Megan Clarken - Dec 13, 2021 Form 4 Insider Report for Criteo S.A. (CRTO)

Role: Chief Executive Officer, Director
Signature: /s/ Ryan Damon, as attorney-in-fact for Megan Clarken
Stock symbol: CRTO
Transactions as of: Dec 13, 2021
Transactions value $: -$4,862,304
Form type: 4
Date filed: 12/15/2021, 03:05 PM
Previous filing: May 14, 2021
Next filing: Feb 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRTO	Ordinary Shares	Sale	-$1.79M	-43.4K	-17.11%	$41.16	210K	Dec 13, 2021	Direct	F1, F2, F3
transaction	CRTO	Ordinary Shares	Options Exercise	$2.4M	+135K	+64.29%	$17.73	345K	Dec 14, 2021	Direct	F1, F3
transaction	CRTO	Ordinary Shares	Sale	-$5.47M	-135K	-39.13%	$40.51	210K	Dec 14, 2021	Direct	F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRTO	Stock Option (right to buy)	Options Exercise	$0	-135K	-40.88%	$0.00	195K	Dec 14, 2021	Ordinary Shares	135K	$17.73	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.
F2	These securities were automatically sold on the reporting person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.
F3	For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.01 to $41.22, inclusive. The reporting person undertakes to provide to any security holder of Criteo S.A. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F5	Stock options granted on December 11, 2019. One-fourth of the grant vests on the first anniversary of the grant date and additional 1/16th of the grant vests quarterly thereafter for a period of 36 months, subject to continued service through each vesting date.